Comments

InMed Pharmaceuticals Stock Price, Quotes and Forecasts

Q: What sector and industry does InMed Pharmaceuticals (INM) operate in?

InMed Pharmaceuticals is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the NASDAQ.

INMNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$2.78

0.020.72%

At close: -

$2.70

-0.08-2.88%

After Hours: 6:41 PM EDT

InMed Pharmaceuticals (INM) Forecast

News Earnings InMed Pharmaceuticals (INM) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

InMed Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:INM | Benzinga

Explore InMed Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for INM.

Open	$2.78
Close	$2.78
Volume / Avg.	15.37K / 91.46K
Day Range	$2.68 - $2.83
52 Wk Range	1.72 - 15.70
Market Cap	$3.26M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	48
Short Interest	2.62%
Days to Cover	1

Recent News

Why Netflix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Crude Oil Down 2%; D.R. Horton Earnings Top Views

Avi Kapoor

Why InMed Pharmaceuticals (INM) Stock Is Skyrocketing

InMed Pharmaceuticals shares are trading higher by 45% during Tuesday's session. The company announced that INM-901 reduced Alzheimer 's-related inflammation in a preclinical study.

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	$2.78
Close	$2.78
Volume / Avg.	15.37K / 91.46K
Day Range	$2.68 - $2.83
52 Wk Range	1.72 - 15.70
Market Cap	$3.26M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	48
Short Interest	2.62%
Days to Cover	1

About

Sector

Healthcare

Industry

N/A

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy InMed Pharmaceuticals (INM) stock?

You can purchase shares of InMed Pharmaceuticals (NASDAQ:INM) through any online brokerage.

View our list of the best stock brokerages

Who are InMed Pharmaceuticals (INM) competitors?

There are no as such competitors for InMed Pharmaceuticals.

What is the forecast, or price target, for InMed Pharmaceuticals (INM) stock?

There is no analysis for InMed Pharmaceuticals to provide a consensus price target.

What is the current price for InMed Pharmaceuticals (INM)?

The stock price for InMed Pharmaceuticals (NASDAQ: INM) is $2.7 last updated May 27, 2025 at 6:41 PM EDT.

Does InMed Pharmaceuticals (INM) pay a dividend?

There are no upcoming dividends for InMed Pharmaceuticals.

When is InMed Pharmaceuticals (NASDAQ:INM) reporting earnings?

InMed Pharmaceuticals’s Q3 earnings are confirmed for Monday, May 12, 2025.

Is InMed Pharmaceuticals (INM) going to split?

There is no upcoming split for InMed Pharmaceuticals.

What sector and industry does InMed Pharmaceuticals (INM) operate in?

InMed Pharmaceuticals is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the NASDAQ.